Glooko and Hedia announced today that launched their interoperable solution for advanced bolus insulin dosing support.

"We believe that 2025 will be a pivotal year for SELLAS as we continue to advance our clinical stage portfolio of novel therapeutics for hematologic malignancies,” said Angelos ...

New integration delivers personalised insulin dosing advice, improving care for people with diabetes and enhancing healthcare provider insights. COPENHAGEN, Denmark and PALO ALTO, Calif.

Glooko’s integration of Hedia’s diabetes tech aims to improve care for patients and enhance healthcare provider insights.

ICON plc, a world-leading clinical research organisation powered by healthcare intelligence, today released the findings of a survey of over 120 biotech and pharma professionals developing treatments ...

Glooko, Inc. and Hedia, today announced the launch of their interoperable solution, which combines connected care, remote ...

New integration delivers personalised insulin dosing advice, improving care for people with diabetes and enhancing healthcare provider insights. Glooko, Inc. and Hedia today announced the launch ...

SQLI, a European digital services group, announces the appointment of Erwan Le Duff as Chief Executive Officer, effective January 1, 2025. He succeeds Philippe Donche-Gay, who has held this position ...

Nov. 20, 2024 — Wings may be the obvious choice when studying the connection between dinosaurs and birds, but a pair of paleontologists prefer drumsticks. That part of the leg, they say, is ...

AI can spot patterns in the data from blood tests that can give an early warning of disease.